PNC Financial Services Group’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $165K | Buy |
5,891
+1,143
| +24% | +$32.2K | ﹤0.01% | 2597 |
|
|
2026
Q1 | $135K | Sell |
4,748
-347
| -7% | -$11.8K | ﹤0.01% | 2609 |
|
|
2025
Q4 | $202K | Sell |
5,095
-1,093
| -18% | -$40.1K | ﹤0.01% | 2312 |
|
|
2025
Q3 | $218K | Buy |
6,188
+380
| +7% | +$13.1K | ﹤0.01% | 2244 |
|
|
2025
Q2 | $190K | Buy |
5,808
+770
| +15% | +$25K | ﹤0.01% | 2244 |
|
|
2025
Q1 | $163K | Sell |
5,038
-186
| -4% | -$6.91K | ﹤0.01% | 2332 |
|
|
2024
Q4 | $160K | Sell |
5,224
-542
| -9% | -$17.4K | ﹤0.01% | 2374 |
|
|
2024
Q3 | $162K | Buy |
5,766
+1,186
| +26% | +$29.2K | ﹤0.01% | 2354 |
|
|
2024
Q2 | $104K | Sell |
4,580
-796
| -15% | -$18.4K | ﹤0.01% | 2606 |
|
|
2024
Q1 | $164K | Sell |
5,376
-764
| -12% | -$25.6K | ﹤0.01% | 2319 |
|
|
2023
Q4 | $219K | Buy |
6,140
+135
| +2% | +$5.02K | ﹤0.01% | 2085 |
|
|
2023
Q3 | $263K | Sell |
6,005
-786
| -12% | -$38.3K | ﹤0.01% | 1923 |
|
|
2023
Q2 | $335K | Buy |
6,791
+286
| +4% | +$13.2K | ﹤0.01% | 1841 |
|
|
2023
Q1 | $270K | Sell |
6,505
-273
| -4% | -$11.3K | ﹤0.01% | 1961 |
|
|
2022
Q4 | $301K | Sell |
6,778
-948
| -12% | -$39.6K | ﹤0.01% | 1855 |
|
|
2022
Q3 | $302K | Buy |
7,726
+786
| +11% | +$36K | ﹤0.01% | 1822 |
|
|
2022
Q2 | $284K | Buy |
6,940
+965
| +16% | +$45.7K | ﹤0.01% | 1908 |
|
|
2022
Q1 | $392K | Buy |
5,975
+1,931
| +48% | +$125K | ﹤0.01% | 1826 |
|
|
2021
Q4 | $281K | Sell |
4,044
-793
| -16% | -$57.6K | ﹤0.01% | 2043 |
|
|
2021
Q3 | $335K | Buy |
4,837
+606
| +14% | +$46.6K | ﹤0.01% | 1875 |
|
|
2021
Q2 | $336K | Sell |
4,231
-549
| -11% | -$39.9K | ﹤0.01% | 1890 |
|
|
2021
Q1 | $313K | Buy |
4,780
+463
| +11% | +$28.5K | ﹤0.01% | 1880 |
|
|
2020
Q4 | $240K | Sell |
4,317
-134
| -3% | -$5.79K | ﹤0.01% | 1950 |
|
|
2020
Q3 | $178K | Sell |
4,451
-253
| -5% | -$10.7K | ﹤0.01% | 2003 |
|
|
2020
Q2 | $212K | Sell |
4,704
-157
| -3% | -$6.84K | ﹤0.01% | 1897 |
|
|
2020
Q1 | $163K | Sell |
4,861
-299
| -6% | -$10.8K | ﹤0.01% | 1931 |
|
|
2019
Q4 | $168K | Sell |
5,160
-6,894
| -57% | -$196K | ﹤0.01% | 2170 |
|
|
2019
Q3 | $301K | Buy |
12,054
+1,575
| +15% | +$45K | ﹤0.01% | 1894 |
|
|
2019
Q2 | $313K | Buy |
10,479
+2,830
| +37% | +$82.6K | ﹤0.01% | 1907 |
|
|
2019
Q1 | $205K | Buy |
7,649
+3,318
| +77% | +$101K | ﹤0.01% | 2131 |
|
|
2018
Q4 | $133K | Buy |
4,331
+2,373
| +121% | +$73.9K | ﹤0.01% | 2296 |
|
|
2018
Q3 | $69K | Buy |
+1,958
| New | +$62K | ﹤0.01% | 2808 |
|
|
2016
Q3 | – | Sell |
-108
| Closed | -$2K | – | 3980 |
|
|
2016
Q2 | $2K | Sell |
108
-47
| -30% | -$716 | ﹤0.01% | 4129 |
|
|
2016
Q1 | $3K | Sell |
155
-1,336
| -90% | -$23.5K | ﹤0.01% | 4014 |
|
|
2015
Q4 | $33K | Buy |
1,491
+188
| +14% | +$3.87K | ﹤0.01% | 3034 |
|
|
2015
Q3 | $28K | Sell |
1,303
-326
| -20% | -$8.15K | ﹤0.01% | 3190 |
|
|
2015
Q2 | $41K | Buy |
1,629
+235
| +17% | +$5.25K | ﹤0.01% | 3137 |
|
|
2015
Q1 | $29K | Sell |
1,394
-31
| -2% | -$601 | ﹤0.01% | 3319 |
|
|
2014
Q4 | $29K | Sell |
1,425
-34
| -2% | -$583 | ﹤0.01% | 3007 |
|
|
2014
Q3 | $21K | Buy |
1,459
+95
| +7% | +$1.51K | ﹤0.01% | 3040 |
|
|
2014
Q2 | $25K | Buy |
1,364
+1,284
| +1,605% | +$21.4K | ﹤0.01% | 2849 |
|
|
2014
Q1 | $2K | Buy |
+80
| New | +$1.64K | ﹤0.01% | 3452 |
|
Other funds holding ATRC
PAM
N
WA
PNC Financial Services Group's ATRC Position: Q2 2026 in Review
PNC Financial Services Group increased its AtriCure (ATRC) stake by 24% in Q2 2026, buying an estimated $32.2K and bringing the position to 5,891 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #2597.
PNC Financial Services Group first reported a position in ATRC in Q1 2014 and has held it in 42 quarters since. The position peaked at $392K in Q1 2022. 107 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- PNC Financial Services Group held 5,891 shares of AtriCure worth $165K as of Q2 2026.
- PNC Financial Services Group bought 1,143 AtriCure shares in Q2 2026, an estimated $32.2K.
- AtriCure made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2597 holding.
- PNC Financial Services Group first reported a position in AtriCure in Q1 2014 and has held it in 42 quarters since.
- PNC Financial Services Group's AtriCure position peaked at $392K in Q1 2022.
- 107 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.